Captions of EuroCD 2023

A week ago, we were bathing in cyclodextrin science in Budapest at the 7th European Cyclodextrin Symposium. As usual, the well-organized event was mainly dominated by European attendees, yet we also met fellows from Japan and the United States too.

Cyclodextrin manufacturers were represented by RoquetteWACKERLigand Pharmaceuticals and Cyclolab R&D Ltd. (the organizer, of course) and I was happy to see several companies focusing on developing cyclodextrin-based therapeutics, such as Beren Therapeutics, Cyclarity TherapeuticsASDERA and CarboHyde.

During the 2,5 days we enjoyed 9 sessions of various topics:

  1. Cyclodextrin production & enzymology
  2. Synthesis of CD derivatives
  3. Cyclodextrin complexes and self-assembly
  4. CDs in drug delivery
  5. Biological effects of CDs
  6. CDs in gene delivery
  7. Environmental applications
  8. Analysis, application in sensing and imaging
  9. Agri-food applications

We had sessions for short presentations and could enjoy 67 posters during the breaks.

Personally, the presentations I found most interesting from academia were

At CarboHyde, we contributed to 6 oral talks and several posters highlighting our active involvement in both industrial and academic cyclodextrin research.

My takeaway is that the event was fantastic, especially due to the great conversations we could enjoy during discussions, breaks, and social events via the joint contribution to our community.

See you all in Dunkerque on the 10th June, 2014 at the International event!

I am really excited already, as Sophie Fourmentin showed great effort to invite CD cyclodextrins from all over the world, so this will truly be a global event. I would be extremely happy if not only global academia, but global pharma with all the several dozen CD users would be present to set good directions for the future of cyclodextrin research.

Dóra Ujj presentation at the Therapeutical Purposes Research and Development Congress at the University of Debrecen

Dóra Ujj (Budapest University of Technology and Economics) presents the results of her collaboration with Milo Malanga Ph.D., Szabolcs Béni, Gábor Benkovics Ph.D. and Tamas Sohajda, among others on analytical and therapeutic applications of Sugammadex analogs at the Therapeutical Purposes Research and Development congress at University of Debrecen.
Thank you for the great organization, if you are close, you should try to attend the 2nd day of the even today with more lectures on cyclodextrin, drug delivery, and pharmaceutical technology.

If you are interested in the details, you can also read the paper published on the topic.